Cargando…
Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2
BACKGROUND: Small cell lung cancers (SCLC) are tumors of neuroendocrine origin. Previous in vitro studies from our laboratory showed that SCLC expresses high levels of the transmembrane dense core vesicle protein IA-2 (islet cell antigen-2) as compared to normal lung cells. IA-2, through its effect...
Autores principales: | Xu, Huanyu, Cai, Tao, Carmona, Gilberto N., Abuhatzira, Liron, Notkins, Abner L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037891/ https://www.ncbi.nlm.nih.gov/pubmed/27670444 http://dx.doi.org/10.1186/s12967-016-1036-0 |
Ejemplares similares
-
Co-regulation of intragenic microRNA miR-153 and its host gene Ia-2β: identification of miR-153 target genes with functions related to IA-2β in pancreas and brain
por: Mandemakers, W., et al.
Publicado: (2013) -
miR-342 inhibits glioma cell proliferation by targeting GPRC5A
por: Wang, Jianjiao, et al.
Publicado: (2019) -
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010) -
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013) -
Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)